Biodesix, Inc. EV/FCF

EV/FCF of BDSX for past 10 years: annual, quarterly and twelve month trailing (TTM) including EV/FCF growth rates and interactive chart. A valuation metric that measures the enterprise value of a stock compared to its free cash flow. Free cash flow is calculated as operating cash flow - capital expenditures and is a more accurate measure of a company's earning power than net income, as it's not easily manipulated. A low EV/FCF ratio can indicate undervaluation, while a high one might mean the growth expectations around the company are elevated. EV/FCF ratio can be compared to different companies in the same industry or to a company’s own historical valuation.

Highlights and Quick Summary

Current EV/FCF of Biodesix, Inc. is -3.97 (as of December 31, 2021)
  • EV/FCF for the quarter ending September 30, 2022 was -1.22 (a -13.99% decrease compared to previous quarter)
  • Year-over-year quarterly EV/FCF decreased by -69.24%
  • Annual EV/FCF for 2021 was -3.97 (a 47.84% increase from previous year)
  • Annual EV/FCF for 2020 was -2.68 (a 7.43% increase from previous year)
  • Annual EV/FCF for 2019 was -2.5 (a -0.0% decrease from previous year)
Visit stockrow.com/BDSX for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical EV/FCF of Biodesix, Inc.

Most recent EV/FCFof BDSX including historical data for past 10 years.

Interactive Chart of EV/FCF of Biodesix, Inc.

Biodesix, Inc. EV/FCF for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 – -1.22 -1.42 -1.43 –
2021 -3.97 -7.28 -13.46 -16.87 -3.97
2020 -2.68 -2.5 -2.5 -2.5 -2.68
2019 – – -2.5 -2.5 -2.5
2018 – – – – -2.5

Business Profile of Biodesix, Inc.

Sector: Healthcare
Industry: Diagnostics & Research
© stockrow.com